medical technology

14 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Stryker Schedules 2026 Annual Meeting, Raises Quarterly Dividend to $0.88

Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.
SYKdividendshareholders
BenzingaBenzinga··Globe Newswire

Nuwellis Expands Renal Care Portfolio with Rendiatech Acquisition

Nuwellis completes acquisition of Rendiatech, adding automated kidney monitoring to its fluid management portfolio for integrated critical care solutions.
NUWEacquisitionmedical technology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

IRADIMED to Present MRI Device Innovation at Roth Conference as Medical Device Market Heats Up

IRADIMED Corporation to present MRI-compatible medical device portfolio at prestigious Roth Conference in March 2026, with CEO and CFO meeting investors directly.
IRMDinvestor conferencemedical technology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifeward Regains Nasdaq Compliance After Stock Price Recovery

Lifeward Ltd. ($LFWD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ending delisting risk for the medical technology company.
LFWDmedical technologyminimum bid price
BenzingaBenzinga··Vandana Singh

NexGel to Triple Revenue With Celularity Biomaterial Portfolio Acquisition

NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.
NXGLNXGLWCELUCELUWacquisitionprofitability
The Motley FoolThe Motley Fool··Joe Tenebruso

3D Systems Stock Surges 27% on Path to Profitability, Strong Sector Growth

$DDD stock jumped 27.30% after reporting strong Q4 revenue growth and significant cost savings, signaling progress toward profitability.
DDDaerospace and defenseprofitability
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Tactile Medical Bolsters Board with Healthcare Executive Andrea Pearson

Tactile Medical ($TCMD) appoints veteran healthcare executive Andrea Pearson to board, strengthening governance with 25+ years of industry scaling expertise.
TCMDmedical technologygrowth strategy
Investing.comInvesting.com··Jeffrey Neal Johnson

Healthcare Giant Johnson & Johnson Outpaces Tech Sector on Dividend Strength

J&J stock hits record highs with 14% monthly returns, outperforming tech due to stable dividends, strong cash flow, and lower volatility amid market uncertainty.
JNJdividend growthpharmaceutical innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Brain-Computer Interface Market Set for Rapid Expansion Through 2035

Brain-computer interface market projected to grow from $3.07B to $13.32B by 2035, driven by technological advances and neurological disorder prevalence.
MDTmarket growthmedical technology
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

TELA Bio Grants 8,550 Restricted Stock Units to New Hires

TELA Bio granted 8,550 restricted stock units to three new hires, vesting over four years. The equity compensation aims to attract talent and promote retention.
TELArestricted stock unitsmedical technology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

NVIDIA, RTI to Demonstrate Real-Time AI Integration Solutions for Medical Devices

NVIDIA and RTI showcase real-time AI integration for medical devices via webinar March 3, 2026, combining Holoscan platform with Connext DDS middleware to streamline edge deployment.
NVDAedge computingDDS
BenzingaBenzinga··Vandana Singh

Tactile Systems Reaches 52-Week Peak on Robust Earnings and Strategic Acquisition

Tactile Systems hits 52-week high on strong Q4 earnings beat and strategic LymphaTech acquisition, with 2026 guidance exceeding expectations.
TCMDacquisitionrevenue growth
BenzingaBenzinga··Globe Newswire

Tactile Medical Bolsters Lymphedema Offerings Through LymphaTech Acquisition

Tactile Medical acquired LymphaTech for $6.8 million, adding 3D digital measurement technology to strengthen its lymphedema treatment portfolio and create integrated diagnostic-therapeutic solutions.
TCMDacquisitionmedical technology
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Investor Stakes $45M Position in Flat-Performing Novanta Stock

ACK Asset Management buys $44.6M stake in underperforming Novanta, betting on cyclical recovery in medical device and industrial automation markets.
NOVTNOVTUMTRNGVAWMSinstitutional investmentmedical technology